Thoracic Oncology Group of Australasia

Thoracic Sector News

Get the latest news, treatments, ASM highlights and topics in lung cancer and mesothelioma from The Thoracic Oncology Group of Australasia (TOGA).

Post Category Filter Radio Buttons
Discover the major advances from TOGA ASM 2026, including lung cancer screening, precision medicine, immunotherapy, survivorship and multidisciplinary care shaping the future of thoracic oncology.
Professor Robert Stirling OAM devoted his career to improving the lives of people with lung cancer through clinical excellence, research, education and compassionate leadership.
The MRFF is holding $1B+ in unspent funds. Learn why TOGA is calling for the release of this research funding to accelerate lung cancer breakthroughs
Discover how 2025 transformed lung cancer care in Australia. Explore the impact of national screening, modern diagnostics, and new PBS treatment approvals.
Learn how TOGA’s ASPiRATION study led to Medicare-funded genomic testing for lung cancer and national best practice guidelines in Australia.
Optimise cancer care for older Adults with practical tips and tools to implement person-centred geriatric oncology.
COSA's new report sheds light on the risks and uncertainties of e-cigarettes. Learn what the science says about vaping, cancer, and public health.
Recommendation by the Medical Services Advisory Committee (MSAC).
The Royal College of Pathologists of Australasia (RCPA), in collaboration with the Thoracic Oncology Group of Australasia (TOGA), has released comprehensive, evidence-based best practice recommendations
As we expand our cancer healthcare, it is essential to explore innovative ways to optimise the role of SCLNs and ensure that patients with lung
Last week brought fantastic news for the fight against lung cancer. The Australian Government announced a record-breaking $1.89 billion investment in health and medical research,
Imagine a world where medical research doesn’t have to start from scratch. Imagine a treasure trove of valuable data readily available to answer new questions